Published in Hospital Law Weekly, November 30th, 2006
This trend article about Hospital Clinico San Carlos, Madrid, Spain, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Research findings, "Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial," are discussed in a new report. "The effects of the CYP3A4 inducer, Hypericum perforatum, on the pharmacokinetics of a single oral dose of ivabradine were assessed. An open-label, 2-period, nonrandomized, phase-I, pharmacokinetic interaction...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly